$EGRX
EAGLE PHARMACEUTICALS, INC. Stock $egrx

$egrx Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000082787120000007 Filed on March 02, 2020

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$48.26M	$41.15M	$56.70M
YoY Change	-13.91%	-19.85%	-4.37%
Cost Of Revenue	$11.59M	$12.14M	$18.18M
YoY Change	-37.55%	40.78%	29.14%
Gross Profit	$36.67M	$26.23M	$35.42M
YoY Change	-2.21%	-31.61%	-13.06%
Gross Profit Margin	75.98%	63.73%	62.46%
Selling, General & Admin	$22.46M	$18.54M	$17.23M
YoY Change	45.09%	33.57%	7.76%
% of Gross Profit	61.25%	70.68%	48.64%
Research & Development	$11.31M	$10.17M	$8.957M
YoY Change	93.0%	70.24%	-41.32%
% of Gross Profit	30.85%	38.79%	25.29%
Depreciation & Amortization	$1.280M	$241.0K	$241.0K
YoY Change	52.38%	-71.31%	-75.66%
% of Gross Profit	3.49%	0.92%	0.68%
Operating Expenses	$33.77M	$43.63M	$47.47M
YoY Change	58.32%	32.48%	-19.7%
Operating Profit	$2.897M	-$2.484M	$9.233M
YoY Change	-81.58%	-113.5%	4945.36%
Interest Expense	-$240.0K	$628.0K	$665.0K
YoY Change	-52.0%	-15.48%	-5.14%
% of Operating Profit	-8.28%		7.2%
Other Income/Expense, Net	$700.0K	-$58.00K	-$28.00K
YoY Change		-92.1%	-96.0%
Pretax Income	$3.360M	-$2.542M	$9.205M
YoY Change	-77.94%	-114.39%	-1880.46%
Income Tax	$2.350M	-$152.0K	$2.480M
% Of Pretax Income	69.94%		26.94%
Net Earnings	$1.010M	-$2.390M	$6.725M
YoY Change	-91.98%	-117.02%	152.91%
Net Earnings / Revenue	2.09%	-5.81%	11.86%
Basic Earnings Per Share	$0.08	-$0.17	$0.49
Diluted Earnings Per Share	$0.08	-$0.17	$0.48
COMMON SHARES
Basic Shares Outstanding	13.67M shares	13.67M shares	13.78M shares
Diluted Shares Outstanding		13.67M shares	14.16M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$109.8M	$117.2M	$108.1M
YoY Change	39.34%	28.51%	7.88%
Cash & Equivalents	$109.8M	$117.2M	$108.1M
Short-Term Investments
Other Short-Term Assets	$1.445M	$1.278M	$266.0K
YoY Change	978.36%	-23.52%	-94.67%
Inventory	$6.566M	$7.247M	$11.59M
Prepaid Expenses
Receivables	$48.00M	$44.81M	$60.34M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$179.4M	$179.8M	$185.7M
YoY Change	9.52%	-9.09%	-7.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.202M	$2.319M	$2.258M
YoY Change	-8.14%	-9.17%	-18.57%
Goodwill	$39.74M	$39.74M	$39.74M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$15.58M	$16.21M	$16.84M
YoY Change	-13.92%	-13.31%	-12.74%
Long-Term Investments
YoY Change
Other Assets	$3.908M	$4.980M	$3.178M
YoY Change	463.11%	605.38%	350.14%
Total Long-Term Assets	$75.11M	$77.25M	$75.97M
YoY Change	0.46%	8.78%	5.02%
TOTAL ASSETS
Total Short-Term Assets	$179.4M	$179.8M	$185.7M
Total Long-Term Assets	$75.11M	$77.25M	$75.97M
Total Assets	$254.6M	$257.0M	$261.6M
YoY Change	6.69%	-4.37%	-4.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.462M	$11.23M	$17.30M
YoY Change	-44.92%	48.89%	-5.31%
Accrued Expenses	$28.36M	$27.13M	$29.45M
YoY Change	20.59%	18.63%	26.82%
Deferred Revenue	$8.364M	$10.40M	$11.70M
YoY Change	42.51%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$5.000M	$5.000M
YoY Change	-20.0%	0.0%	-20.0%
Total Short-Term Liabilities	$38.82M	$42.36M	$51.75M
YoY Change	-2.17%	19.62%	8.4%
LONG-TERM LIABILITIES
Long-Term Debt	$33.56M	$35.69M	$35.84M
YoY Change	-12.05%	-9.22%	-11.43%
Other Long-Term Liabilities	$3.000M	$3.227M	$1.560M
YoY Change
Total Long-Term Liabilities	$36.56M	$38.91M	$37.40M
YoY Change	-4.19%	-1.01%	-7.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.82M	$42.36M	$51.75M
Total Long-Term Liabilities	$36.56M	$38.91M	$37.40M
Total Liabilities	$75.38M	$81.27M	$89.15M
YoY Change	-3.16%	8.77%	1.07%
SHAREHOLDERS EQUITY
Retained Earnings	$72.50M	$71.50M	$73.89M
YoY Change	24.6%	56.8%	134.12%
Common Stock	$17.00K	$17.00K	$17.00K
YoY Change	0.0%	6.25%	6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$171.9M	$168.9M	$168.9M
YoY Change	11.67%	63.31%	84.97%
Treasury Stock Shares	2.908M shares	2.855M shares	2.855M shares
Shareholders Equity	$179.2M	$175.8M	$172.5M
YoY Change
Total Liabilities & Shareholders Equity	$254.6M	$257.0M	$261.6M
YoY Change	6.69%	-4.37%	-4.49%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$1.010M	-$2.390M	$6.725M
YoY Change	-91.98%	-117.02%	152.91%
Depreciation, Depletion And Amortization	$1.280M	$241.0K	$241.0K
YoY Change	52.38%	-71.31%	-75.66%
Cash From Operating Activities	-$3.200M	$10.62M	$22.39M
YoY Change	-108.4%	187.8%	294.89%
INVESTING ACTIVITIES
Capital Expenditures	-$130.0K	-$310.0K	-$160.0K
YoY Change	62.5%	933.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$130.0K	-$310.0K	-$160.0K
YoY Change	62.5%	933.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.110M	-1.230M	-16.23M
YoY Change	-91.85%	-90.3%	1388.99%
NET CHANGE
Cash From Operating Activities	-3.200M	10.62M	22.39M
Cash From Investing Activities	-130.0K	-310.0K	-160.0K
Cash From Financing Activities	-4.110M	-1.230M	-16.23M
Net Change In Cash	-7.440M	9.080M	6.000M
YoY Change	-40.19%	-200.67%	31.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.200M	$10.62M	$22.39M
Capital Expenditures	-$130.0K	-$310.0K	-$160.0K
Free Cash Flow	-$3.070M	$10.93M	$22.55M
YoY Change	-108.04%	193.82%	297.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000827871
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16504283	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16537846	shares
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1500000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.2856
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.4376
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5073
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3763
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4376
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4083
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0242
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0307
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0261
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0170
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0230
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0142
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38823000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2590258	shares
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	50 Tice Boulevard
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33557000	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 315
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2907687	shares
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-36306
CY2019	dei	Entity Registrant Name EntityRegistrantName	Eagle Pharmaceuticals, Inc.
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38155000	USD
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8179278
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Woodcliff Lake
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07677
CY2019	dei	City Area Code CityAreaCode	201
CY2019	dei	Local Phone Number LocalPhoneNumber	326-5300
CY2019	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2019	dei	Trading Symbol TradingSymbol	EGRX
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	677440631	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13679350	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109775000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78791000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48004000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66486000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	6566000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	8304000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2202000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	75380000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	77841000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2397000	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15583000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18103000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	179449000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	163844000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39686000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15104000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10263000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	39743000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	39743000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13669000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13822000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3908000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	694000	USD
CY2019Q4	us-gaap	Assets Assets	254554000	USD
CY2018Q4	us-gaap	Assets Assets	238603000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5462000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9917000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28361000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23519000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6250000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	36616000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	73990000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	162717000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	21815000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	278518000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	256458000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	72500000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	58187000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	171861000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	153900000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	179174000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	160762000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	254554000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	238603000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	195892000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213312000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236707000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47891000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42374000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33714000	USD
CY2019	us-gaap	Royalty Expense RoyaltyExpense	13006000	USD
CY2018	us-gaap	Royalty Expense RoyaltyExpense	19542000	USD
CY2017	us-gaap	Royalty Expense RoyaltyExpense	23472000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36810000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44419000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32607000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	76370000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	60509000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	71416000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	7911000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2704000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7235000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-763000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7377000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2018	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2017	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1650000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	174077000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	176696000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	-4877000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	73105000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	2169000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	158000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	91000	USD
CY2019	us-gaap	Interest Expense InterestExpense	2686000	USD
CY2018	us-gaap	Interest Expense InterestExpense	2736000	USD
CY2017	us-gaap	Interest Expense InterestExpense	1136000	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	700000	USD
CY2018	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2017	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	183000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2578000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1045000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21998000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	34038000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	72945000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7685000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2135000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21002000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14313000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	31903000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51943000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.04
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.44
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.09
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.27
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13754516	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14768625	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15102890	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14138733	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15278651	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15908211	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	151226000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15429000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4338000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	43792000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51943000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	179144000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19082000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8615000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	260000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	31903000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	160762000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-21998000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-21998000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	260000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	198000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	198000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17961000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17961000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	14313000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	179174000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	14313000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	31903000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51943000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	152000	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2468000	USD
CY2017	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	17289000	USD
CY2019	us-gaap	Depreciation Depreciation	2131000	USD
CY2018	us-gaap	Depreciation Depreciation	1155000	USD
CY2017	us-gaap	Depreciation Depreciation	932000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2520000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2515000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2815000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	21998000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	19082000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	15429000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-763000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7377000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	480000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	376000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	222000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2704000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7235000	USD
CY2019	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2018	us-gaap	Restructuring Costs RestructuringCosts	5769000	USD
CY2017	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18481000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12665000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5556000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2379000	USD
CY2019	egrx	Increase Decreasein Prepaid Expenseand Other Current Assets Total IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal	4841000	USD
CY2018	egrx	Increase Decreasein Prepaid Expenseand Other Current Assets Total IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal	-4838000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11627000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1739000	USD
CY2017	egrx	Increase Decreasein Prepaid Expenseand Other Current Assets Total IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal	-1993000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	599000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	570000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4455000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2064000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8460000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4067000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8128000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-9096000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55986000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52384000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58919000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	777000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4436000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	750000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-777000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5186000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17961000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	73105000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	43792000	USD
CY2019	egrx	Paymentsfor Contingent Consideration PaymentsforContingentConsideration	0	USD
CY2018	egrx	Paymentsfor Contingent Consideration PaymentsforContingentConsideration	15000000	USD
CY2017	egrx	Paymentsfor Contingent Consideration PaymentsforContingentConsideration	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	50000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3750000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1250000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	326000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1192000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	198000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	egrx	Payments For Employee Options Exercised PaymentsForEmployeeOptionsExercised	0	USD
CY2018	egrx	Payments For Employee Options Exercised PaymentsForEmployeeOptionsExercised	4877000	USD
CY2017	egrx	Payments For Employee Options Exercised PaymentsForEmployeeOptionsExercised	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	260000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8615000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4338000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24225000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-88117000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8104000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	30984000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35866000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61837000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78791000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114657000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52820000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109775000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78791000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114657000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	6673000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	2281000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	10542000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	2478000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	2084000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	651000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3716000	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2017	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019Q4	egrx	Number Of Products NumberOfProducts	2	product
CY2019Q4	egrx	Number Of Products NumberOfProducts	2	product
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	75000000.0	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	USD
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1348563	shares
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	73100000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2590258	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	153900000	USD
CY2017Q3	egrx	Clinical Development Cost Sharing Percentage ClinicalDevelopmentCostSharingPercentage	0.50
CY2017Q3	egrx	License Agreement Proceeds From Upfront Payment LicenseAgreementProceedsFromUpfrontPayment	12500000	USD
CY2019	egrx	License Agreement Potential Milestone Payments LicenseAgreementPotentialMilestonePayments	10000000.0	USD
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These financial statements are presented in U.S. dollars and are prepared in accordance with U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements including disclosure of contingent assets and contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company's critical accounting policies are those that are both most important to the Company's financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results may materially vary from these estimates.</span></div>
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</span></div>Certain reclassifications have been made to prior year amounts to conform with the current year presentation.
CY2017	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	17770000	USD
CY2019	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2374000	USD
CY2018	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3312000	USD
CY2017	egrx	License Agreement Proceeds From Upfront Payment LicenseAgreementProceedsFromUpfrontPayment	12500000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	14313000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	31903000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51943000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13754516	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14768625	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15102890	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	384217	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	510026	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	805321	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14138733	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15278651	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15908211	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.04
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.44
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.09
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.27
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2460000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6303000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3243000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1776000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	863000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	225000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	6566000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	8304000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6521000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5744000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4319000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3347000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2202000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2397000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	972000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1155000	USD
CY2019Q4	egrx	Advancestocommercialmanufactures Advancestocommercialmanufactures	2462000	USD
CY2018Q4	egrx	Advancestocommercialmanufactures Advancestocommercialmanufactures	2700000	USD
CY2019Q4	egrx	Prepaid Fda User Fee PrepaidFDAUserFee	6345000	USD
CY2018Q4	egrx	Prepaid Fda User Fee PrepaidFDAUserFee	1540000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	191000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	150000	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	4661000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	5739000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1445000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	134000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15104000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10263000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6004000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	7139000	USD
CY2019Q4	egrx	Accrued Researchand Development Current AccruedResearchandDevelopmentCurrent	1686000	USD
CY2018Q4	egrx	Accrued Researchand Development Current AccruedResearchandDevelopmentCurrent	1245000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1926000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2408000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8083000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	5049000	USD
CY2019Q4	egrx	Accrued Product Costs Current AccruedProductCostsCurrent	8364000	USD
CY2018Q4	egrx	Accrued Product Costs Current AccruedProductCostsCurrent	5869000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2298000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1809000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28361000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23519000	USD
CY2019	egrx	Number Of Operating Leases NumberOfOperatingLeases	2	lease
CY2019	egrx	Number Of Operating Leases NumberOfOperatingLeases	2	lease
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3716000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3000000	USD
CY2019	egrx	Operating Lease Rightof Use Asset Depreciation OperatingLeaseRightofUseAssetDepreciation	1159000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1146000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	952000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1146000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2019Q4	egrx	Number Of Operating Leases NumberOfOperatingLeases	2	lease
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6607000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1345000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1362000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1376000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1291000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	820000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	413000	USD
CY2018	egrx	Number Of Operating Leases NumberOfOperatingLeases	2	lease
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3661000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1146000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	864000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	583000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	583000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	485000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	5000000	USD
CY2019Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	400000	USD
CY2019Q4	egrx	Unamortized Prepaid Expense UnamortizedPrepaidExpense	900000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26000000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	39000000	USD
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	75000000.0	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	USD
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	317429	shares
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1348563	shares
CY2017	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	674857	shares
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17961000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	73105000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	43792000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1934193	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2786568	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	57.13
CY2017Q4	egrx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber	1349339	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1437229	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	672092	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	59.17
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	502322	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.19
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	399973	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2556365	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.78
CY2018Q4	egrx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber	1074456	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1481909	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	628133	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.28
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23032	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.33
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	65305	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3096161	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	59.29
CY2019Q4	egrx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber	1070054	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2026107	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.18
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	26.73
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	32.83
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	19051000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2019	egrx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercised Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedIntrinsicValue	1068000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	31900000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10700000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33700000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21998000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19082000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15429000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21998000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19082000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15429000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6689000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4137000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1304000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	844000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	466000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2409000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7533000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4603000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3713000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	392000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2565000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	18045000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-240000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	97000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-756000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	152000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2468000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17289000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7685000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2135000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21002000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03
CY2019	egrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit	-0.01
CY2018	egrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit	0.11
CY2017	egrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit	0.04
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.02
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.07
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.10
CY2019	egrx	Effective Income Tax Rate Reconciliation Limitation On Executive Compensation Percent EffectiveIncomeTaxRateReconciliationLimitationOnExecutiveCompensationPercent	0.10
CY2018	egrx	Effective Income Tax Rate Reconciliation Limitation On Executive Compensation Percent EffectiveIncomeTaxRateReconciliationLimitationOnExecutiveCompensationPercent	0.03
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0.05
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.04
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.35
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.06
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.29
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	243000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10647000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7934000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3251000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1539000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1767000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	51000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	732000	USD
CY2019Q4	egrx	Deferred Tax Assets In Process Researchand Development Credit DeferredTaxAssetsInProcessResearchandDevelopmentCredit	620000	USD
CY2018Q4	egrx	Deferred Tax Assets In Process Researchand Development Credit DeferredTaxAssetsInProcessResearchandDevelopmentCredit	761000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	662000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	925000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1017000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	64000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15704000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14509000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	280000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	43000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	34000	USD
CY2019Q4	egrx	Deferred Tax Liabilities Fixed Assets DeferredTaxLiabilitiesFixedAssets	203000	USD
CY2018Q4	egrx	Deferred Tax Liabilities Fixed Assets DeferredTaxLiabilitiesFixedAssets	282000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	838000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	91000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1084000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	687000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	951000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13669000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13822000	USD
CY2017	us-gaap	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	3400000	USD
CY2017Q3	egrx	Clinical Development Cost Sharing Percentage ClinicalDevelopmentCostSharingPercentage	0.50
CY2017Q3	egrx	License Agreement Proceeds From Upfront Payment LicenseAgreementProceedsFromUpfrontPayment	12500000	USD
CY2019	egrx	Product Development Agreements Exclusive Rights Acquired Numberof Products ProductDevelopmentAgreementsExclusiveRightsAcquiredNumberofProducts	33	product
CY2019	egrx	Marketing Rights Term MarketingRightsTerm	P10Y
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6607000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1345000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1362000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1376000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1291000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	820000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	413000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	39000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	18329000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	18329000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2019Q4	egrx	Obligations Future Payments ObligationsFuturePayments	63936000	USD
CY2019Q4	egrx	Obligations Future Payments Due Remainder Of Fiscal Year ObligationsFuturePaymentsDueRemainderOfFiscalYear	24674000	USD
CY2019Q4	egrx	Obligations Future Payments Due In Second Year ObligationsFuturePaymentsDueInSecondYear	9362000	USD
CY2019Q4	egrx	Obligations Future Payments Due In Third Year ObligationsFuturePaymentsDueInThirdYear	27376000	USD
CY2019Q4	egrx	Obligations Future Payments Due In Fourth Year ObligationsFuturePaymentsDueInFourthYear	1291000	USD
CY2019Q4	egrx	Obligations Future Payments Due In Fifth Year ObligationsFuturePaymentsDueInFifthYear	820000	USD
CY2019Q4	egrx	Obligations Future Payments Due Thereafter ObligationsFuturePaymentsDueThereafter	413000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1146000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	571000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	664000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6607000	USD
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	18329000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23100000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7517000	USD
CY2019Q4	egrx	Finite Lived Intangible Assets Impairment FiniteLivedIntangibleAssetsImpairment	0	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15583000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34320000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6278000	USD
CY2018Q4	egrx	Finite Lived Intangible Assets Impairment FiniteLivedIntangibleAssetsImpairment	9939000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18103000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2520000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2515000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2815000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2666000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2623000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1369000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1570000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1570000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5785000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15583000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49785000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56702000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41147000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48258000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	195892000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	36685000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	35418000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	26225000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	36667000	USD
CY2019	us-gaap	Gross Profit GrossProfit	134995000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	12169000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	9233000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2484000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	2897000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	21815000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8973000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6725000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2390000	USD
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1005000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14313000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.64
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.04
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46626000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59296000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51337000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56053000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213312000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	34818000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	40737000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	38346000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	37495000	USD
CY2018	us-gaap	Gross Profit GrossProfit	151396000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2305000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	183000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	18402000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	15726000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	36616000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2616000	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2659000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14040000	USD
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12588000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	31903000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.09
CY2018	us-gaap	Restructuring Charges RestructuringCharges	7911000	USD

Files In Submission

Name	View Source	Status
0000827871-20-000007-index-headers.html	Edgar Link	pending
0000827871-20-000007-index.html	Edgar Link	pending
0000827871-20-000007.txt	Edgar Link	pending
0000827871-20-000007-xbrl.zip	Edgar Link	pending
chart-12d78d31ea5053ce94c.jpg	Edgar Link	pending
egrx-20191231.xsd	Edgar Link	pending
egrx-20191231_cal.xml	Edgar Link	unprocessable
egrx-20191231_def.xml	Edgar Link	unprocessable
egrx-20191231_lab.xml	Edgar Link	unprocessable
egrx-20191231_pre.xml	Edgar Link	unprocessable
egrx10k2019.htm	Edgar Link	pending
egrx10k2019_htm.xml	Edgar Link	completed
exhibit1032fifthamendm.htm	Edgar Link	pending
exhibit1034lily-eaglep.htm	Edgar Link	pending
exhibit1035-tymexeagle.htm	Edgar Link	pending
exhibit21110k2019.htm	Edgar Link	pending
exhibit23110k2019.htm	Edgar Link	pending
exhibit31110k2019.htm	Edgar Link	pending
exhibit31210k2019.htm	Edgar Link	pending
exhibit32110k2019.htm	Edgar Link	pending
exhibit43-descriptiono.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EGRX
EAGLE PHARMACEUTICALS, INC. Stock $egrx

2019 Q4 Form 10-K Financial Statement

#000082787120000007 Filed on March 02, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EGRX EAGLE PHARMACEUTICALS, INC. Stock $egrx

2019 Q4 Form 10-K Financial Statement

#000082787120000007 Filed on March 02, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EGRX
EAGLE PHARMACEUTICALS, INC. Stock $egrx